Tuesday, April 2, 2019

Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them? by GINA KOLATA


By GINA KOLATA

Drugs to prevent organ rejection are not always covered for patients who had transplants before they enrolled in Medicare.

Published: April 1, 2019 at 08:00PM

from NYT Health https://ift.tt/2CQNI7l
via IFTTT



from WordPress https://ift.tt/2FTmpv7
via IFTTT

No comments:

Post a Comment